Latest 10-K annual reports

NASDAQ
DarioHealth Corp. reported a decrease in 2025 revenues and continued net losses, alongside significant operational efficiency gains and customer growth, while initiating a strategic review to maximize shareholder value.
NASDAQ
Future FinTech Group Inc. reports a significant reduction in net loss for fiscal year 2025, driven by gains from discontinued operations and debt restructuring, amidst ongoing business transformation and legal challenges.
NASDAQ
AEye, Inc. reports a 4% reduction in net loss and 15% revenue growth in 2025, driven by new product launches and strategic partnerships, while continuing to navigate significant market and financial challenges.
AMEX
Gold Resource Corporation reports improved Q4 production and a significant cash increase in 2025, alongside a definitive merger agreement with Goldgroup Mining Inc. for Q2 2026.
NASDAQ
Dogwood Therapeutics reports significant R&D investment and clinical trial progress for its pain and neuropathy pipeline, alongside substantial net losses and ongoing capital needs.
NASDAQ
TEN Holdings, Inc. reported a substantial net loss of $19.5 million for fiscal year 2025, driven by decreased revenue and increased operating expenses, raising going concern doubts.
NASDAQ
4D Molecular Therapeutics reports significant progress in its gene therapy pipeline, including positive clinical data for 4D-150 and 4D-710, and a major collaboration with Otsuka Pharmaceutical, while navigating substantial net losses and a strategic workforce reduction.
NASDAQ
Avidbank Holdings reported a net loss of $19.6 million in 2025, driven by a $62.4 million loss from repositioning its available-for-sale securities portfolio, following its initial public offering in August 2025.
NASDAQ
Ovid Therapeutics Inc. reported a reduced net loss for 2025, driven by increased revenue and successful capital raises, as it advances its pipeline of brain disorder treatments.
NYSE
Home Depot reports mixed fiscal 2025 results with net sales up 3.2% to $164.7 billion driven by acquisitions, but net earnings and EPS declined, while strategic investments in Pro and interconnected experience continue.
NASDAQ
Hyperfine, Inc. reports continued net losses and negative cash flow for FY 2025 despite significant product innovation and strategic commercial expansion for its AI-powered portable MRI system.
NYSE
Energy Vault Holdings, Inc. reported significant revenue growth and reduced net losses in 2025, driven by its expanding 'Own & Operate' strategy and new ventures into AI infrastructure.
NYSE
Best Buy reports fiscal 2026 revenue of $41.7 billion with comparable sales growth of 0.5%, driven by computing and mobile phones, alongside strategic investments in Best Buy Ads and Marketplace.
NASDAQ
Sera Prognostics, a women's health company, reported a reduced net loss in 2025, bolstered by a recent capital raise and positive clinical trial results for its PreTRM test, while expanding its executive team and product pipeline.
NASDAQ
Bitcoin Depot reports a net income drop and anticipates a significant revenue decline in 2026 due to heightened regulatory pressures and fraud mitigation efforts, despite operational growth and strategic acquisitions.
NASDAQ
Usio, Inc. reported a 3% revenue increase to $85.4 million in 2025, driven by strong ACH and complementary services growth, despite a net loss of $2.5 million and declines in prepaid card services.
NASDAQ
Lifeward Ltd. reported a 14% revenue decrease to $22.0 million in 2025, alongside a reduced net loss, but acknowledged substantial doubt about its ability to continue as a going concern.
OQX
Peoples Financial Corporation reported a significant decline in net income for 2025, driven by lower interest income and increased non-interest expenses, despite a decrease in interest expense.
AMEX
Mastech Digital, Inc. reported a 3.8% decline in total revenues for fiscal year 2025 to $191.4 million, driven by reduced client spending and lower bookings in its Data and Analytics Services segment and a decrease in billable consultants in IT Staffing.
NASDAQ
Neonode Inc. reported a net income of $8.5 million for fiscal year 2025, primarily due to a significant gain from a patent assignment, despite a 33.7% decrease in total net revenues.
NYSE
Viking Acquisition Corp. I, a blank check company, filed its annual report detailing its initial public offering, trust account status, and search for a business combination target.
AMEX
Protalix BioTherapeutics reported its financial results for the fiscal year ended December 31, 2025, highlighting a net loss and increased R&D expenses while advancing its rare disease pipeline and securing a new Elfabrio dosing approval in the EU.
Vyome Holdings, Inc. reported a significant net loss for fiscal year 2025, while advancing its lead drug candidate VT-1953 for malignant fungating wounds and outlining plans for future clinical trials and capital raises.
NYSE
Bob's Discount Furniture achieved significant revenue and profit growth in fiscal year 2025, driven by new store openings and strong comparable sales, while successfully completing its Initial Public Offering in early 2026.
NASDAQ
Art Technology Acquisition Corp. outlines its blank check company structure, IPO proceeds, and strategy for identifying and completing an initial business combination in the technology, art, and financial services sectors.
NASDAQ
Telomir Pharmaceuticals, a preclinical-stage biotech, reports progress on its lead compound Telomir-1 and announces a merger with TELI Pharmaceuticals to consolidate global intellectual property rights, despite ongoing net losses and a going concern warning.
NASDAQ
ClearPoint Neuro reports increased revenue and significant net losses in 2025, driven by the IRRAS acquisition and new debt financing, while advancing its neurosurgical and drug delivery platforms.
NASDAQ
Harte Hanks, a global Business Experience Outsourcing company, reported a 13.9% revenue decrease and a net loss of $0.811 million for the fiscal year ended December 31, 2025.
NASDAQ
Gaxos.AI experienced a significant revenue surge in 2025 driven by new AI product launches and health services, yet reported a wider net loss as operating expenses, particularly marketing, escalated.
NASDAQ
Meshflow Acquisition Corp.'s annual report outlines its authorized securities, SPAC structure, and strategic focus on the blockchain and digital asset ecosystem, alongside financial results for 2025.